Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Richard David Wyss, Ph.D.

Concepts (72)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Propensity Score9202217231.360 Why?
Pharmacoepidemiology120222980.740 Why?
Vitiligo22022930.430 Why?
Research Design4202058400.430 Why?
Dermatitis, Atopic320226180.420 Why?
Conjunctivitis220221500.400 Why?
Hidradenitis Suppurativa220221430.360 Why?
Delivery of Health Care2202247330.330 Why?
Opportunistic Infections220203840.320 Why?
Proportional Hazards Models22020124130.290 Why?
Models, Statistical2201850560.250 Why?
Psoriasis220229830.230 Why?
Conjunctivitis, Bacterial12022220.230 Why?
Cohort Studies52022395630.230 Why?
Alopecia Areata12022930.210 Why?
Conjunctivitis, Allergic120221270.210 Why?
Systemic Vasculitis12020250.200 Why?
Computer Simulation5202260470.200 Why?
Scleroderma, Localized12020760.190 Why?
Sjogren's Syndrome120202330.180 Why?
Connective Tissue Diseases120202390.170 Why?
Algorithms12018136240.160 Why?
Phototherapy120203440.160 Why?
Databases, Factual3202277750.150 Why?
Peer Review120171960.140 Why?
Epidemiologic Research Design120183640.140 Why?
Likelihood Functions120189940.130 Why?
Product Surveillance, Postmarketing120184770.120 Why?
Bacterial Infections1202014280.110 Why?
Biological Products120208470.100 Why?
Colitis, Ulcerative1202218210.100 Why?
Immunosuppressive Agents2202242120.100 Why?
Crohn Disease1202222820.090 Why?
Venous Thromboembolism1202115160.090 Why?
Research1201720200.090 Why?
Inflammatory Bowel Diseases1202222890.080 Why?
Regression Analysis1201865150.080 Why?
Asthma1202258280.060 Why?
Humans1420227070670.060 Why?
Risk Assessment32020234840.060 Why?
Monte Carlo Method2201913030.060 Why?
Logistic Models12018136180.060 Why?
Incidence32022205320.050 Why?
Adrenergic Antagonists12018240.050 Why?
Cyclosporine120228270.050 Why?
Data Interpretation, Statistical2201927400.040 Why?
Time Factors12020412510.040 Why?
Angioedema120181770.040 Why?
Methotrexate1202217090.030 Why?
Anticoagulants2201942310.030 Why?
Angiotensin-Converting Enzyme Inhibitors1201814670.030 Why?
Administration, Oral1201939480.030 Why?
Warfarin1201814370.020 Why?
United States Food and Drug Administration1201817760.020 Why?
Adolescent32021851590.020 Why?
United States32020670260.020 Why?
Insurance, Health1202024840.020 Why?
Chronic Disease1202289920.020 Why?
Hemorrhage1201831940.020 Why?
Longitudinal Studies12020135810.020 Why?
Young Adult22021560580.020 Why?
Child22022737070.020 Why?
Adult320222119890.010 Why?
Severity of Illness Index12020161490.010 Why?
Atrial Fibrillation1201943610.010 Why?
Middle Aged320212151660.010 Why?
Male320203512630.010 Why?
Aged220201623200.010 Why?
Stroke1201891960.010 Why?
Female320203766420.010 Why?
Risk Factors12021700660.010 Why?
Aged, 80 and over12018586650.010 Why?
Wyss's Networks
Click the
buttons for more information and interactive visualizations!
Concepts (72)
Co-Authors (9)
Similar People (60)
Same Department 
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.